Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 24 04:00PM ET
33.90
Dollar change
-0.10
Percentage change
-0.29
%
IndexS&P 500 P/E- EPS (ttm)-0.46 Insider Own0.44% Shs Outstand507.63M Perf Week-3.83%
Market Cap17.27B Forward P/E10.60 EPS next Y3.20 Insider Trans-2.80% Shs Float507.31M Perf Month-15.73%
Income-233.00M PEG- EPS next Q0.66 Inst Own90.87% Short Float1.97% Perf Quarter-19.29%
Sales14.89B P/S1.16 EPS this Y12.05% Inst Trans0.70% Short Ratio2.62 Perf Half Y-5.49%
Book/sh16.04 P/B2.11 EPS next Y9.80% ROA-0.14% Short Interest10.02M Perf Year-19.52%
Cash/sh5.94 P/C5.71 EPS next 5Y4.07% ROE-0.54% 52W Range31.01 - 50.21 Perf YTD-12.31%
Dividend Est.1.20 (3.55%) P/FCF24.19 EPS past 5Y- ROI-1.18% 52W High-32.48% Beta0.61
Dividend TTM1.16 (3.42%) Quick Ratio1.01 Sales past 5Y6.04% Gross Margin36.91% 52W Low9.32% ATR (14)0.74
Dividend Ex-DateMay 31, 2024 Current Ratio1.48 EPS Y/Y TTM90.57% Oper. Margin9.76% RSI (14)19.23 Volatility1.57% 2.01%
Employees60000 Debt/Eq1.73 Sales Y/Y TTM-1.08% Profit Margin-1.56% Recom2.56 Target Price43.28
Option/ShortYes / Yes LT Debt/Eq1.41 EPS Q/Q-16.36% Payout- Rel Volume1.30 Prev Close34.00
Sales Surprise1.08% EPS Surprise7.01% Sales Q/Q-1.56% EarningsMay 02 BMO Avg Volume3.82M Price33.90
SMA20-7.08% SMA50-14.25% SMA200-12.05% Trades Volume4,982,119 Change-0.29%
Date Action Analyst Rating Change Price Target Change
May-10-24Downgrade TD Cowen Buy → Hold $40
May-30-23Resumed Morgan Stanley Equal-Weight $45
Mar-29-23Initiated UBS Neutral $43
Jan-06-23Downgrade Morgan Stanley Overweight → Equal-Weight $55
Jan-05-23Downgrade Raymond James Outperform → Mkt Perform
Jan-03-23Downgrade BofA Securities Buy → Neutral $66 → $55
Dec-19-22Downgrade JP Morgan Overweight → Neutral $68 → $55
Dec-15-22Downgrade Deutsche Bank Buy → Hold $69 → $51
Dec-12-22Downgrade Citigroup Buy → Neutral $64 → $58
Oct-18-22Initiated Barclays Overweight $64
May-24-24 09:40AM
May-23-24 04:15PM
May-15-24 02:00PM
May-14-24 12:21PM
May-13-24 10:45AM
09:28AM Loading…
09:28AM
08:45AM
May-10-24 06:17AM
May-07-24 04:15PM
08:30AM
May-03-24 12:47PM
11:31AM
09:03AM
07:37AM
07:14AM
03:09AM Loading…
03:09AM
01:08AM
May-02-24 07:00PM
01:00PM
11:30AM
10:03AM
08:52AM
08:33AM
08:28AM
08:25AM
07:23AM
07:15AM
Apr-29-24 09:16AM
08:31AM
Apr-26-24 10:48AM
01:46PM Loading…
Apr-23-24 01:46PM
Apr-12-24 11:00AM
Apr-11-24 08:30AM
Apr-10-24 04:15PM
11:58AM
10:00AM
Apr-02-24 12:08PM
Apr-01-24 08:24PM
07:15AM
Mar-28-24 03:24PM
Mar-27-24 09:00AM
Mar-26-24 05:00PM
Mar-14-24 03:57AM
Mar-13-24 08:21AM
Mar-06-24 11:50PM
Mar-05-24 05:00PM
10:07AM
Mar-04-24 06:19AM
Feb-29-24 04:15PM
Feb-23-24 05:43AM
Feb-21-24 07:07PM
04:00PM
Feb-17-24 03:32AM
Feb-15-24 07:41AM
Feb-13-24 02:18PM
Feb-12-24 06:15PM
Feb-09-24 05:03PM
10:43AM
12:31AM
12:14AM
Feb-08-24 12:06PM
11:05AM
09:30AM
08:40AM
08:27AM
07:50AM
07:38AM
07:15AM
Feb-05-24 09:16AM
08:52AM
Jan-04-24 04:15PM
Dec-22-23 09:00AM
Dec-15-23 10:45PM
01:28PM
Dec-14-23 08:00AM
08:00AM
07:42AM
Dec-13-23 04:30PM
Dec-11-23 07:58PM
04:22PM
09:00AM
Dec-04-23 08:00AM
Nov-28-23 09:00AM
Nov-22-23 04:01PM
Nov-14-23 04:30PM
10:03AM
Nov-07-23 08:00AM
Nov-06-23 08:30AM
Nov-04-23 01:24PM
Nov-03-23 01:12AM
12:37AM
Nov-02-23 10:30PM
03:02PM
10:56AM
09:04AM
08:47AM
07:35AM
07:15AM
07:11AM
Nov-01-23 06:27PM
Baxter International, Inc. engages in the provision of a portfolio of essential healthcare products including acute and chronic dialysis therapies, sterile intravenous (IV) solutions, infusion systems and devices, parenteral nutrition therapies, inhaled anesthetics, generic injectable pharmaceuticals, surgical hemostat and sealant products, surgical equipment, smart bed systems, patient monitoring and diagnostic technologies, and respiratory health devices. It operates through the following segments: Americas, Europe, Middle East and Africa (EMEA), Asia-Pacific (APAC), and Hillrom. The Americas, EMEA, and APAC segments offer a portfolio of essential healthcare products. The Hillrom segment provides digital and connected care solutions and collaboration tools, including smart bed systems, patient monitoring and diagnostic technologies, respiratory health devices, and equipment for the surgical space. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Mason Jeanne KEVP, Chief HR OfficerMar 01 '24Option Exercise37.1764,4882,397,019206,778Mar 05 04:15 PM
Mason Jeanne KEVP, Chief HR OfficerMar 01 '24Sale40.6164,4882,618,858142,290Mar 05 04:15 PM